Ghanem G - Search Results

1

Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: a corollary study to EORTC trial 18952.

Bouwhuis MG, Suciu S, Kruit W, Salès F, Stoitchkov K, Patel P, Cocquyt V, Thomas J, Liénard D, Eggermont AM, Ghanem G; European Organisation for Research and Treatment of Cancer Melanoma Group. Bouwhuis MG, et al. Among authors: ghanem g. Eur J Cancer. 2011 Feb;47(3):361-8. doi: 10.1016/j.ejca.2010.10.005. Epub 2010 Nov 17. Eur J Cancer. 2011. PMID: 21087856 Clinical Trial.

2

An accurate method for cytostatic dosimetry in isolation perfusion based on limb vascular volume determination.

Lejeune FJ, Ghanem GE, Liénard D, Ewalenko P. Lejeune FJ, et al. Among authors: ghanem ge. Antibiot Chemother (1971). 1988;40:63-76. doi: 10.1159/000415212. Antibiot Chemother (1971). 1988. PMID: 3415204 No abstract available.

3

Increased serum alpha-melanocyte stimulating hormone (alpha-MSH) in human malignant melanoma.

Ghanem G, Liénard D, Hanson P, Lejeune F, Frühling J. Ghanem G, et al. Eur J Cancer Clin Oncol. 1986 Apr;22(4):535-6. doi: 10.1016/0277-5379(86)90125-2. Eur J Cancer Clin Oncol. 1986. PMID: 3732358 No abstract available.

4

alpha-Melanotropin immunoreactivity in human melanoma exudate is related to necrosis.

Loir B, Sales F, Deraemaecker R, Morandini R, Garcia-Borron JC, Ghanem G. Loir B, et al. Among authors: ghanem g. Eur J Cancer. 1998 Feb;34(3):424-6. doi: 10.1016/s0959-8049(97)10016-8. Eur J Cancer. 1998. PMID: 9640235

5

On the release and half-life of S100B protein in the peripheral blood of melanoma patients.

Ghanem G, Loir B, Morandini R, Sales F, Lienard D, Eggermont A, Lejeune F; EORTC Melanoma Group. Ghanem G, et al. Int J Cancer. 2001 Nov;94(4):586-90. doi: 10.1002/ijc.1504. Int J Cancer. 2001. PMID: 11745448 Free article.

6

Melanoma progression and serum L-dopa/L-tyrosine ratio: a comparison with S100B.

Stoitchkov K, Letellier S, Garnier JP, Bousquet B, Tsankov N, Morel P, Ghanem G, Le Bricon T. Stoitchkov K, et al. Among authors: ghanem g. Melanoma Res. 2002 Jun;12(3):255-62. doi: 10.1097/00008390-200206000-00009. Melanoma Res. 2002. PMID: 12140382

7

Evaluation of the serum L-dopa/L-tyrosine ratio as a melanoma marker.

Stoitchkov K, Letellier S, Garnier JP, Bousquet B, Tsankov N, Morel P, Ghanem G, Le Bricon T. Stoitchkov K, et al. Among authors: ghanem g. Melanoma Res. 2003 Dec;13(6):587-93. doi: 10.1097/00008390-200312000-00008. Melanoma Res. 2003. PMID: 14646622

8

High serum galectin-3 in advanced melanoma: preliminary results.

Vereecken P, Zouaoui Boudjeltia K, Debray C, Awada A, Legssyer I, Sales F, Petein M, Vanhaeverbeek M, Ghanem G, Heenen M. Vereecken P, et al. Among authors: ghanem g. Clin Exp Dermatol. 2006 Jan;31(1):105-9. doi: 10.1111/j.1365-2230.2005.01992.x. Clin Exp Dermatol. 2006. PMID: 16309497

9

Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma.

Pedeux R, Sales F, Pourchet J, Kallassy M, Fayolle C, Boniol M, Severi G, Ghanem G, Nakazawa HN, Autier P, Doré JF. Pedeux R, et al. Among authors: ghanem g. Eur J Cancer. 2006 Jan;42(2):212-5. doi: 10.1016/j.ejca.2005.09.021. Epub 2005 Dec 7. Eur J Cancer. 2006. PMID: 16337788

10

Defining the prognostic value for galectin-3 in cutaneous melanoma.

Vereecken P, Ghanem G, Morandini R, Suciu S, Van Baren N, Heenen M. Vereecken P, et al. Among authors: ghanem g. J Int Med Res. 2007 Sep-Oct;35(5):731-2. doi: 10.1177/147323000703500520. J Int Med Res. 2007. PMID: 17900410 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page